MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
HSIC stock logo

HSIC

Henry Schein, Inc.

$80.03
1.98
 (2.54%)
Exchange:  NASDAQ
Market Cap:  9.117B
Shares Outstanding:  2.18B
Delayed data
Calculate HSIC Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Distribution
   
CEO:  Andrea Albertini
Full Time Employees:  25000
Address: 
135 Duryea Road
Melville
NY
11747
US
Website:  https://www.henryschein.com
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/05/05 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue12,339,00012,673,00013,184,000
Gross Profit3,651,0003,765,0003,842,000
EBITDA877,000941,0001,006,000
Operating Income714,000729,000758,000
Net Income416,000390,000398,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets10,573,00010,218,00011,215,000
Total Liabilities5,420,0005,381,0006,421,000
Total Stockholders Equity3,655,0003,393,0003,245,000
Total Debt2,741,0002,870,0003,687,000
Cash and Cash Equivalents171,000122,000156,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow500,000848,000712,000
Capital Expenditure-187,000-187,000-139,000
Free Cash Flow313,000661,000573,000
Net Income416,000398,000398,000
Net Change in Cash54,000-49,00034,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2029Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)14,901,247.301Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)15,201,216.854Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)15,034,700Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)1,133,986.552Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)1,156,814.268Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)1,144,142.317Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)853,819.530Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)876,224.340Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)863,787.588Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)3,401,040.846Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)3,469,505.497Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)3,431,499.912Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)6.760Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)6.860Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)6.680Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)2Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
12.673B  ?P/S
 (TTM)
: 
0.66
?Net Income
 (TTM)
: 
390M  ?P/E
 (TTM)
: 
22.54
?Enterprise Value
 (TTM)
: 
12.434B  ?EV/FCF
 (TTM)
: 
28.85
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
0.12  ?ROIC
 (TTM)
: 
0.06
?Net Debt
 (TTM)
: 
2.748B  ?Debt/Equity
 (TTM)
: 
1.15
?P/B
 (TTM)
: 
2.73  ?Current Ratio
 (TTM)
: 
1.36

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
14.96Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates HSIC intrinsic value between $72.41 – $76.12 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about HSIC valuation

Is Henry Schein, Inc. (HSIC) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Henry Schein, Inc. (HSIC) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is HSIC a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether HSIC trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is HSIC’s P/E ratio?

You can see HSIC’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for HSIC?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is HSIC a good long-term investment?

Whether HSIC fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

HSIC

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

2.54
MARKETSnap

Trading Metrics:

Open: 78.5   Previous Close: 78.05
Day Low: 78.5   Day High: 80.83
Year Low: 61.95   Year High: 89.29
Price Avg 50: 74.74   Price Avg 200: 73.2
Volume: 2.084M   Average Volume: 1.374M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Henry Schein, Inc. (HSIC) Presents at Stifel Jaws & Paws Conference 2026 Transcript
27-05-2026 17:07
Henry Schein, Inc. (HSIC) Presents at Stifel Jaws & Paws Conference 2026 Transcript
Henry Schein One Releases 2026 Catalyst Index, Revealing Clinical Performance as the Primary Driver of Growth
14-05-2026 06:30
Henry Schein One Releases 2026 Catalyst Index, Revealing Clinical Performance as the Primary Driver of Growth
HSIC Q1 Earnings & Revenues Surpass Estimates, Gross Margin Rises
05-05-2026 10:16
HSIC Q1 Earnings & Revenues Surpass Estimates, Gross Margin Rises
Henry Schein Reports First Quarter 2026 Financial Results
05-05-2026 06:00
Henry Schein Reports First Quarter 2026 Financial Results
Why Henry Schein (HSIC) is Poised to Beat Earnings Estimates Again
17-04-2026 13:11
Why Henry Schein (HSIC) is Poised to Beat Earnings Estimates Again
Henry Schein (HSIC) Down 9.4% Since Last Earnings Report: Can It Rebound?
26-03-2026 12:32
Henry Schein (HSIC) Down 9.4% Since Last Earnings Report: Can It Rebound?

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read